Gw Pharmaceuticals Plc Stock Market Capitalization
GW Pharmaceuticals Plc fundamentals help investors to digest information that contributes to GW Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of GWPRF OTC Stock. The fundamental analysis module provides a way to measure GW Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GW Pharmaceuticals otc stock.
GWPRF |
GW Pharmaceuticals Plc OTC Stock Market Capitalization Analysis
GW Pharmaceuticals' Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current GW Pharmaceuticals Market Capitalization | 6.44 B |
Most of GW Pharmaceuticals' fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GW Pharmaceuticals Plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
CompetitionBased on the recorded statements, the market capitalization of GW Pharmaceuticals Plc is about 6.44 B. This is much higher than that of the sector and significantly higher than that of the Market Capitalization industry. The market capitalization for all United States stocks is notably lower than that of the firm.
GWPRF Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GW Pharmaceuticals' direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of GW Pharmaceuticals could also be used in its relative valuation, which is a method of valuing GW Pharmaceuticals by comparing valuation metrics of similar companies.GW Pharmaceuticals is currently under evaluation in market capitalization category among related companies.
GWPRF Fundamentals
| Return On Equity | -9.62 | |||
| Return On Asset | -4.58 | |||
| Profit Margin | (12.49) % | |||
| Operating Margin | (11.73) % | |||
| Current Valuation | 120.65 M | |||
| Shares Outstanding | 378.54 M | |||
| Shares Owned By Insiders | 1.99 % | |||
| Shares Owned By Institutions | 13.60 % | |||
| Price To Earning | 10.80 X | |||
| Price To Book | 0.73 X | |||
| Price To Sales | 11.51 X | |||
| Revenue | 559.04 M | |||
| Gross Profit | 489.67 M | |||
| EBITDA | (51.65 M) | |||
| Net Income | (69.84 M) | |||
| Cash And Equivalents | 458.1 M | |||
| Cash Per Share | 14.52 X | |||
| Total Debt | 42.5 M | |||
| Debt To Equity | 0.06 % | |||
| Current Ratio | 4.49 X | |||
| Book Value Per Share | 23.35 X | |||
| Cash Flow From Operations | (20.51 M) | |||
| Earnings Per Share | (2.22) X | |||
| Number Of Employees | 1.16 K | |||
| Beta | 1.65 | |||
| Market Capitalization | 6.44 B | |||
| Total Asset | 453 M | |||
| Retained Earnings | (178 M) | |||
| Working Capital | 370 M | |||
| Current Asset | 405 M | |||
| Current Liabilities | 35 M | |||
| Z Score | 91.6 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Consideration for investing in GWPRF OTC Stock
If you are still planning to invest in GW Pharmaceuticals Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the GW Pharmaceuticals' history and understand the potential risks before investing.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |